CD133, also known as Prominin-1, is a five-transmembrane glycoprotein that is critical in several cancer-related processes, including tumorigenesis, metastasis, and resistance to chemotherapy and radiotherapy [103]. The gene discussed is PROM1; the disease is cancer.